Market Overview
Arthroscopy devices include visualization systems such as arthroscopes, shavers, ablation tools, and related accessories used by orthopedic surgeons to diagnose and treat joint conditions through small incisions. The European market represents one of the world's largest regional segments, with Germany, the United Kingdom, and France leading in both procedure volume and device adoption. Regulatory compliance with the European Union Medical Device Regulation (EU MDR) shapes product lifecycle management, quality standards, and operational costs for manufacturers operating in the region.
- •The market is valued at approximately $2.42 billion in 2025 and growing at 4.21% annually
- •Germany, the United Kingdom, France, and Italy are the dominant country markets in Europe
- •EU MDR compliance is a defining regulatory framework influencing quality standards and manufacturer operations
Growth Drivers
Rising prevalence of bone-related and musculoskeletal disorders, including osteoarthritis and sports injuries, is a primary catalyst for increased arthroscopic procedures across Europe. An aging demographic profile across the region correlates with higher incidence of degenerative joint conditions requiring surgical intervention. Advancements in minimally invasive technology, including improved imaging resolution and precision instrumentation, continue to expand the range of conditions treatable via arthroscopy.
- •Increasing prevalence of osteoarthritis and bone-related disorders fuels demand for arthroscopic procedures
- •Growing elderly population leads to higher rates of degenerative joint conditions requiring surgical treatment
- •Technological improvements in arthroscopic instrumentation and imaging expand treatable indications
Segmentation and Regional Analysis
The market is typically segmented by product type, including arthroscopes, shavers, ablation devices, visualization systems, and accessories, as well as by application such as knee, shoulder, hip, ankle, and wrist procedures. Germany commands the largest country share in Europe at approximately 29% of the regional market, followed by the United Kingdom at around 22%, reflecting strong healthcare infrastructure and high orthopedic surgical volumes in these nations.
- •Germany holds approximately 29% of the European arthroscopy market share, the largest single-country portion
- •The United Kingdom accounts for roughly 22% of Europe's total market share
- •France and Italy are also significant markets, each forecasted to grow at over 4% annually
Trends and Outlook
What are the recent trends and outlook?
The market is expected to continue expanding through the early 2030s, with robotics-assisted arthroscopy and advanced navigation systems emerging as transformative technologies with growing clinical adoption. Increasing emphasis on outpatient and ambulatory surgery centers is reshaping procurement patterns and device utilization. Regulatory harmonization under EU MDR is expected to consolidate market positions, favoring manufacturers with robust quality management systems.
- •Robotics-assisted and navigation-enabled arthroscopy procedures are gaining clinical adoption across European hospitals
- •Shift toward ambulatory surgery centers is influencing device procurement and procedural workflows
- •Market consolidation under EU MDR regulations is expected to favor well-capitalized, quality-focused manufacturers
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.